Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling

Wessen Maruwge1, Pádraig D’Arcy1, Annika Folin1,2, Slavica Brnjic1, Johan Wejde1, Anthony Davis1, Fredrik Erlandsson3, Jonas Bergh1,2, Bertha Brodin11Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; 2Radiumhemmet, Karolinska University Hosp...

Full description

Bibliographic Details
Main Authors: Wessen Maruwge, Pádraig D’Arcy, Annika Folin, Slavica Brnjic, Johan Wejde, et al
Format: Article
Language:English
Published: Dove Medical Press 2008-11-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/sorafenib-inhibits-tumor-growth-and-vascularization-of-rhabdomyosarcom-a2640